one of my goals for this year was to read more. i haven’t set a target, and i’m focusing on the journey instead. 📚📖
currently enjoying the hell out of @Schreiberland’s the theory of everything else.
what are you reading?
Ever wondered what you cat really thinks about you? The latest studies on the minds of cats may make you see your pet in a whole new light https://t.co/bxdmR6TKw1
Nxt weekend, Saathi, IIT Bombay LGBTQ 🏳️🌈support group is going to organise its 1st ever annual festival, Rangavali ’23.
We will have movie screening, panel discussion, conversation, workshop on inclusive classroom, quiz, fashion show and many more.
Stay tuned for more details.
A very insightful session and a must have in the burgeoning field of Organoids. But a lot was discussed particularly on equity and access to patented drugs by all countries. Stimulating conversations!!!!
Every now and then, I find a paper with so many problems that I will share the DOI.
This paper was cited 184 times, and funded by @NIH, @AmericanCancer, @UChicago Cancer Research Center, and UChicago Friends of Dermatology Endowment Fund.
All problems found by eye.
/
So happy and proud to have the privilege of nominating Shubha @shubhatole my postdoc mentor for this award. I and several others bask in the glory of your mentorship!!!
The 1000 Indian genomes
A phenomenal indian contribution to world genomics. This should be used as a reference while interpreting Indian data of exomes and genomes.
Kudos @vinodscaria @SridharSivasub3 @IGIBSocial
In conversation with Dr N Kalaiselvi, the first woman to serve as the Director of @CSIR_IND, as she discusses her journey and the role of CSIR in India's technology journey
My article for the September issue of the official E-newsletter of @PrinSciAdvGoI
https://t.co/0jTLiHzX6S
Access to menstrual hygiene products is the right of every woman. The system be cognizant of it and ensure this is met.
Its unfortuante that in India most institutes do not even consider this as a priority.
#menstrualhygiene#tampons#pads#WomensRights#women
This review provides an overview #azelnidipine for #hypertension control, including comparisons with traditional calcium channel blockers. It discusses the key antihypertensive effects as well as its prevention of #tachycardia and associated complications: https://t.co/suixeCuSmx
We are partnering with @Cactusglobal to create researcher training programs.
We are delighted to share that we have received an overwhelming response of about 500+ applications for this program. Read more here 👇
https://t.co/7qrY18ZpGl
@Shantala @SmitaJainIISc@abgo29
Ummm No.
This only reinforces the need for accurate science reporting.
Combination hyperbole and inaccurate reporting fuels misinformation.
Some brief thoughts (bear with the slightly rambling nature 😉)
1/n